Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Unveiling Lilly (LLY) Q4 Outlook: Wall Street Estimates for Key Metrics
10:20am, Friday, 30'th Jan 2026
Get a deeper insight into the potential performance of Lilly (LLY) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some
FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?
09:53am, Friday, 30'th Jan 2026
Orforglipron is a promising weight loss pill that could be a huge growth catalyst for Eli Lilly. The Food and Drug Administration has pushed back the target action date on the drug by nearly two weeks
Why Dividend Stocks Are Essential For What Comes Next
07:30am, Friday, 30'th Jan 2026
Why Dividend Stocks Are Essential For What Comes Next
Should You Buy Eli Lilly Before Feb. 4?
07:15am, Friday, 30'th Jan 2026
Eli Lilly will need an outstanding performance, likely driven by tirzepatide, to see its shares jump after its quarterly update on Feb. 4. Even if that doesn't happen, there are ample reasons to buy t
Eli Lilly: Obesity Pricing For Access Tradeoff A Net Positive
04:51pm, Thursday, 29'th Jan 2026
Eli Lilly enters 2026 with strong commercial momentum, pipeline wins, and shares near all-time highs. The company's strategic price cuts for Zepbound and commitment to a low-priced launch of orforglip
Eli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 Billion
01:58pm, Thursday, 29'th Jan 2026
Repertoire Immune Medicines entered a strategic collaboration on Thursday with Eli Lilly and Co. (NYSE: LLY) to develop tolerizing therapies for multiple autoimmune diseases.
Trump says Eli Lilly to build six US plants
01:05pm, Thursday, 29'th Jan 2026
U.S. President Donald Trump said on Thursday that he has spoken to the head of pharmaceutical company Eli Lilly and that the company plans to build six plants in the country.
Prediction: Artificial Intelligence (AI) Will Reshape This Industry by 2030. This Stock Could Lead.
08:05am, Thursday, 29'th Jan 2026
This pharmaceutical giant is increasingly looking unstoppable.
Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies
06:31am, Thursday, 29'th Jan 2026
Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based biotech said on Th
Eaton Vance Worldwide Health Sciences Fund Reduces Stake in Novo Nordisk AS by 49.25%
03:01pm, Wednesday, 28'th Jan 2026
Exploring Strategic Moves in the Health Sciences Sector Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) recently submitted its N-PORT filing for
Will Lilly (LLY) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Wednesday, 28'th Jan 2026
Lilly (LLY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Eli Lilly partners with Seamless Therapeutics on gene editing treatments for hearing loss
11:24am, Wednesday, 28'th Jan 2026
Eli Lilly and Co (NYSE:LLY) announced that it has entered a strategic global research collaboration and licensing agreement with Seamless Therapeutics to develop and commercialize programmable recombi
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
11:00am, Wednesday, 28'th Jan 2026
Lilly (LLY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Wednesday, 28'th Jan 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Some of Pharma's Biggest Brands Face a New Reality
09:48am, Wednesday, 28'th Jan 2026
Big pharma just got another nudge from Washington that Medicare pricing pressure is only moving in one direction. A new batch of well-known drugs from Pfizer (P
